0001127602-24-016107.txt : 20240521 0001127602-24-016107.hdr.sgml : 20240521 20240521160303 ACCESSION NUMBER: 0001127602-24-016107 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240520 FILED AS OF DATE: 20240521 DATE AS OF CHANGE: 20240521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Deschatelets Pascal CENTRAL INDEX KEY: 0001657720 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38276 FILM NUMBER: 24969231 MAIL ADDRESS: STREET 1: 6400 WESTWIND WAY STREET 2: SUITE A CITY: CRESTWOOD STATE: KY ZIP: 40014 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Apellis Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001492422 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 271537290 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-977-5700 MAIL ADDRESS: STREET 1: 100 FIFTH AVENUE CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4.xml PRIMARY DOCUMENT X0508 4 2024-05-20 0001492422 Apellis Pharmaceuticals, Inc. APLS 0001657720 Deschatelets Pascal C/O APELLIS PHARMACEUTICALS, INC. 100 FIFTH AVENUE, 3RD FLOOR WALTHAM MA 02451 1 Chief Scientific Officer 0 Common Stock 2024-05-20 4 M 0 24500 3.76 A 1140483 D Stock Option (Right to Buy) 3.76 2024-05-20 4 M 0 24500 0 D 2026-02-06 Common Stock 24500 12780 D This stock option was granted on 02/08/2016 and is fully vested. /s/ David Watson, attorney-in-fact for Pascal Deschatelets 2024-05-21